Cargando…
Effects of rituximab treatment on the serum concentrations of vitamin D and interleukins 2, 6, 7, and 10 in patients with rheumatoid arthritis
BACKGROUND: Rituximab, a monoclonal antibody that selectively targets CD20-positive B-lymphocytes, is used for the treatment of patients with rheumatoid arthritis (RA) with an inadequate response or tolerance to tumor necrosis factor inhibitors. The objective of this study was to investigate the eff...
Autores principales: | Hasan, Eman, Olusi, Samuel, Al-Awadhi, Adel, Mokaddem, Khalid, Sharma, Prem, George, Sunila |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3280863/ https://www.ncbi.nlm.nih.gov/pubmed/22355257 http://dx.doi.org/10.2147/BTT.S27840 |
Ejemplares similares
-
Serum anti-modified citrullinated vimentin antibody concentration is associated with liver fibrosis in patients with chronic hepatitis
por: Abdeen, Suad, et al.
Publicado: (2011) -
Rituximab for Rheumatoid Arthritis
por: Cohen, Marc D., et al.
Publicado: (2015) -
Tuberculosis Arthritis in the Wrist While Using Rituximab for Rheumatoid Arthritis Treatment
por: Ulusoy, Hasan, et al.
Publicado: (2020) -
Immunoregulatory role of interleukin 10 in rheumatoid arthritis
Publicado: (1994) -
Safety, Tolerability, and Efficacy of Tocilizumab in Rheumatoid Arthritis: An Open-Label Phase 4 Study in Patients from the Middle East
por: Hammoudeh, Mohammed, et al.
Publicado: (2015)